P2-436: GWAS IDENTIFIES <i>CD1A</i> AFFECTING THE RATE OF PLASMA NEUROFILAMENT LIGHT INCREASE IN NONDEMENTED ELDERS

Zuo-teng Wang,Jin-Tai Yu

DOI: https://doi.org/10.1016/j.jalz.2019.06.2843

2019-01-01

Abstract:The plasma neurofilament light (NFL) levels reflect the preclinical neurodegeneration in Alzheimer's disease (AD). In a genome-wide association study (GWAS), baseline plasma NFL data were used as endophenotypes to explore genetic factors and identified a new AD risk locus. Since inter-individual variability may exist in the disease trajectories, we performed a GWAS using a quantitative measure of the rate of change in plasma NFL levels. Five hundred forty-five qualified non-Hispanic white participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) with longitudinal plasma NFL data were included. Linear mixed models were utilized to compute longitudinal rates of change in the plasma NFL levels. Additive genetic model was utilized to explore associations between the rate of change in plasma NFL and genetic polymorphisms. Linear mixed models were used to estimate associations between genotypes and other AD-related phenotypes. Kaplan-Meier survival and Cox regression analyses were utilized to explore the impact of genetic variant on clinical disease progression. Three SNPs (rs16840041, p=4.50×10−8; rs2269714, p=4.50×10−8; rs2269715, p=4.83×10−8) in CD1A were significantly associated with the rate of change in plasma NFL. The three SNPs were in linkage disequilibrium (LD). The minor allele (A) of rs16840041 was significantly associated with faster rates of [18F]-Fluorodeoxyglucose (FDG) decline (estimate -1.6% per year [95% CI −0.6 to -2.6], p=0.0024). Subjects with minor allele (A) showed significantly shorter estimated time of clinical disease progression (4.86 ± 0.50 years, 95% CI 3.90–5.82, p = 0.006).